Qilu Pharmaceutical Co., Ltd. drugs
5 results
Daptomycin (daptomycin)
(Daptomycin)Qilu Pharmaceutical Co., Ltd.
Usage: Please provide the name of the drug you would like summarized.
Ertapenem (ertapenem sodium)
(ertapenem sodium)Qilu Pharmaceutical Co., Ltd.
Usage: Ertapenem is indicated for treating complicated intra-abdominal infections, complicated skin infections (including diabetic foot infections), community-acquired pneumonia, complicated urinary tract infections, acute pelvic infections, and for prophylaxis of surgical site infections following elective colorectal surgery in patients aged three months and older.
Imatinib mesylate (imatinib mesylate)
(imatinib mesylate)Qilu Pharmaceutical Co., Ltd.
Usage: This drug is indicated for treating newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), and various myelodysplastic/myeloproliferative diseases, among other conditions, including aggressive systemic mastocytosis and gastrointestinal stromal tumors.
Irinotecan hydrochloride (irinotecan hydrochloride)
(Irinotecan Hydrochloride)Qilu Pharmaceutical Co., Ltd.
Usage: Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colorectal carcinoma and for patients whose disease has recurred or progressed after initial fluorouracil-based treatment.
Meropenem (meropenem)
(Meropenem)Qilu Pharmaceutical Co., Ltd.
Usage: Meropenem for injection is indicated for complicated skin and skin structure infections, complicated intra-abdominal infections, and bacterial meningitis in pediatric patients. It targets specific bacteria including Staphylococcus aureus (methicillin-susceptible), Escherichia coli, and Neisseria meningitidis, with caution to reduce drug-resistant bacteria development.